TARO-RAMIPRIL
Identification of Taro-Ramipril
| No description |
Google image searchProduct monograph
Active ingredient
ramipril, 2.5 MG
DIN: 02310511
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: SUN PHARMA CANADA INC
Date: 10-FEB-2020
ATC:
- C09 — AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM (ATC, ATC/DDD, )
- C09A — ACE INHIBITORS, PLAIN (ATC, ATC/DDD)
- C09AA — ACE inhibitors, plain (ATC, ATC/DDD)
- C09AA05 — RAMIPRIL (ATC/DDD)
Reference brand drug: Altace
Pharmaceutical standard: USP
